Largest market shown
Germany
$226.7B calculated opportunity across 92 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$226.7B calculated opportunity across 92 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $226.7B | 92 | Reported | 2,189 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United KingdomGBR | $122.5B | 42 | Reported | 1,892 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| NetherlandsNLD | $115.2B | 34 | Reported | 2,023 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, LiechtensteinCHE | $81.6B | 12 | Reported | 2,617 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $58.8B | 29 | Reported | 2,235 km | 4 | Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 |
| BelgiumBEL | $39.4B | 15 | Reported | 2,133 km | 5 | Product not reported |
| ItalyITA | $35.9B | 12 | Reported | 3,308 km | 11 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts |
| PolandPOL | $34.1B | 25 | Reported | 2,773 km | 37 | Telephones for cellular networks or for other wireless networks |
| SpainESP | $23.6B | 13 | Reported | 2,895 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| CzechiaCZE | $22.9B | 13 | Reported | 2,640 km | 25 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $19.1B | 8 | Reported | 1,499 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| RussiaRUS | $18.1B | 8 | Not reported | 3,316 km | 10 | Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc |
| SloveniaSVN | $11.1B | 2 | Reported | 3,000 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| DenmarkDNK | $9.7B | 5 | Reported | 2,111 km | 4 | Vehicles: with only electric motor for propulsion |
| SwedenSWE | $9.4B | 7 | Reported | 2,138 km | 8 | Vehicles: with only electric motor for propulsion |
| GreeceGRC | $8.1B | 3 | Reported | 4,167 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| NorwayNOR | $6.6B | 3 | Reported | 1,750 km | 4 | Vehicles: with only electric motor for propulsion |
| AustriaAUT | $6.0B | 4 | Reported | 2,892 km | 21 | Telephones for cellular networks or for other wireless networks |
| HungaryHUN | $5.8B | 5 | Reported | 3,078 km | 7 | Telephones for cellular networks or for other wireless networks |
| SlovakiaSVK | $3.6B | 2 | Reported | 2,933 km | 22 | Telephones for cellular networks or for other wireless networks |
| RomaniaROU | $3.0B | 3 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FinlandFIN | $2.1B | 2 | Reported | 2,425 km | 13 | Product not reported |
| PortugalPRT | $1.9B | 2 | Reported | 2,953 km | 7 | Product not reported |
| UkraineUKR | $1.4B | 1 | Reported | 3,379 km | 7 | Product not reported |
| CroatiaHRV | $1.0B | 1 | Reported | 3,089 km | 20 | Product not reported |
| LuxembourgLUX | $1.0B | 1 | Reported | 2,319 km | 17 | Product not reported |
| Bosnia and HerzegovinaBIH | $846.7M | 1 | Reported | 3,377 km | 80 | Product not reported |
| The former Yugoslav Republic of MacedoniaMKD | $810.5M | 1 | Reported | 3,687 km | 15 | Product not reported |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 4 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 5 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $17.3B | +12.8% | +0.0% |
| 6 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 7 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 8 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 9 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.0% |
| 10 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 11 | ItalyITA | HS 293719Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.8B | +29.0% | +0.0% |
| 12 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 13 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 14 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 15 | RussiaRUS | HS 870322Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc | $8.5B | +16.6% | +0.0% |
| 16 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 17 | NetherlandsNLD | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.3B | +4.0% | +0.0% |
| 18 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 19 | United KingdomGBR | HS 851712Telephones for cellular networks or for other wireless networks | $6.7B | +7.5% | +0.0% |
| 20 | GermanyDEU | HS 851762Communication apparatus (excluding telephone sets or base stations): machines for the reception, conversion and transmission or regeneration of voice, images or other data, including switching and routing apparatus | $6.0B | +11.4% | +0.0% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 85
77 screened products with $287.0B of reported buyer imports.
$164.5BCalculated opportunity · +11.1% average growthHS2 30
41 screened products with $299.2B of reported buyer imports.
$140.3BCalculated opportunity · +12.1% average growthHS2 87
57 screened products with $254.0B of reported buyer imports.
$112.1BCalculated opportunity · +12.8% average growthHS2 00
30 screened products with $217.2B of reported buyer imports.
$95.3BCalculated opportunity · +8.4% average growthHS2 84
39 screened products with $139.8B of reported buyer imports.
$86.0BCalculated opportunity · +7.2% average growthHS2 71
14 screened products with $219.9B of reported buyer imports.
$81.3BCalculated opportunity · +10.3% average growthHS2 27
6 screened products with $89.1B of reported buyer imports.
$45.4BCalculated opportunity · +5.4% average growthHS2 29
8 screened products with $34.8B of reported buyer imports.
$34.4BCalculated opportunity · +15.8% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.